155431-40-6 Usage
General Description
4-(2,4-Difluorophenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one, also known as rufinamide, is a synthetic antiepileptic drug that is primarily used to prevent seizures in patients with Lennox-Gastaut syndrome, a severe form of epilepsy. Rufinamide works by modulating the activity of sodium channels in the brain, which helps to stabilize the electrical activity of neurons and reduce the occurrence of abnormal electrical impulses that can trigger seizures. This medication is typically taken orally and has been shown to be effective in reducing the frequency of seizures in patients with Lennox-Gastaut syndrome when used as part of a comprehensive treatment plan. Side effects of rufinamide can include dizziness, drowsiness, and nausea, and it may also interact with other medications, so it should be used under the supervision of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 155431-40-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,4,3 and 1 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 155431-40:
(8*1)+(7*5)+(6*5)+(5*4)+(4*3)+(3*1)+(2*4)+(1*0)=116
116 % 10 = 6
So 155431-40-6 is a valid CAS Registry Number.
155431-40-6Relevant articles and documents
Azole compounds, their production and use
-
, (2008/06/13)
An azole compound represented by the formula (I): STR1 wherein Ar is a substituted phenyl group; R1 and R2 independently are a hydrogen atom or a lower alkyl group, or R1 and R2 may combine together to form a lower alkylene group; R3 is a group bonded through a carbon atom; R4 is a hydrogen atom or an acyl group; X is a nitrogen atom or a methine group; and n Y and Z independently are a nitrogen atom or a methine group which may optionally be substituted with a lower alkyl group, or a salt thereof, which is useful for prevention and therapy of fungal infections of mammals as antifungal agent.
